Implantable Medical Devices
Mott works with medical device manufacturers and pharmaceutical companies to provide life-saving treatment solutions for patients suffering from chronic and acute diseases. From biopsy site markers for radiation therapy, to low-flow, controlled release elements for implantable medical devices, Mott partners with scientists and engineers to design and manufacture reliable parts that improve patient comfort and compliance, and increase treatment efficacy. Mott’s experience in flow control and materials science ensures part performance and bio-inertness, thereby mitigating host rejection.
Questions? Call 860.747.6333 Today!
Related Resources
Typical Applications:
- Subcutaneous Drug Delivery
- Implantable Devices
- Biomarkers
Ultra-Low Flow Drug Delivery
Sintered porous metal for use in sustained release of therapeutic agents to optimize patient outcomes. Ultra-low flow drug delivery device components.
Implantable Controlled Release Drug Delivery Testing
Let Mott conduct your initial drug diffusion feasibility studies to guide the design criteria for your next-generation, controlled-release drug delivery technology.
Lab & Engineering Services
Discover our entire range of services, including rapid prototyping, filter feasibility, media characterization and more.
Explore Mott's Capabilities
Provides an overview of markets served, applications, products, materials, and engineering capabilities.
What is an implantable medical device?
An implantable medical device is a specially designed apparatus intended to be placed inside or on the body’s surface to address various medical conditions. These devices can range from pacemakers to drug delivery systems. Made from biocompatible materials, they seamlessly integrate into the body, ensuring both safety and optimal performance. Mott’s commitment to innovation ensures that these devices meet the highest standards for patient care.
FAQs: Implantable Medical Devices
Q: What services does Mott provide in relation to implantable medical devices?
A: Mott collaborates with medical device manufacturers and pharmaceutical companies to offer life-saving treatment solutions for patients with chronic and acute diseases. They provide solutions ranging from biopsy site markers for radiation therapy to low-flow, controlled release elements for implantable drug devices. Mott’s expertise in flow control and materials science ensures the performance and bio-inertness of the parts, reducing the risk of host rejection.
Q: What are the typical applications of Mott’s implantable devices?
A: The typical applications of Mott’s implantable devices include:
Subcutaneous Drug Delivery
Implantable Devices
Biomarkers
Q: How does Mott ensure the reliability of their implantable devices?
A: Mott partners with scientists and engineers to design and manufacture parts that enhance patient comfort and compliance and boost treatment efficacy. Their experience in flow control and materials science guarantees the performance of the parts and can also be bio-inert, which helps in reducing the chances of host rejection.
Q: What is the significance of ultra-low flow drug delivery in Mott’s implantable devices?
A: Mott uses porous materials for sustained release of therapeutic agents to optimize patient outcomes. The ultra-low flow drug delivery device components ensure a controlled and consistent release of drugs, enhancing the treatment’s effectiveness.
Q: What additional services does Mott offer?
A: Mott offers a range of services, including rapid prototyping, filter feasibility, media characterization, and more, to support the development and implementation of their implantable devices.
